iBio Inc.

iBio Inc.
Stock Exchange NYSE
EPS
$1.06
Market Cap
$13.59 M
Shares Outstanding
19.7 M
Public Float
17.95 M

Profile

Address
600 Madison Avenue
New York New York 10022
United States
Employees -
Website http://www.ibioinc.com
Updated 07/08/2019
iBio, Inc. operates as a biotechnology company, which focuses on using its proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators, and third-party customers as well as developing and commercializing its own product candidates. It operates through the iBio, Inc. and iBio CDMO business segments. The iBio CDMO segment is a subsidiary of the company, which develops and manufactures plant-made pharmaceuticals.

Financials

View All
Created with Highcharts 5.0.14iBio Inc.Net Income. Fiscal year is July-June. All values USD Thousands.6 1986 1983 6663 6666 6256 6259 7649 76414 53214 53216 10516 10520132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14iBio Inc.Sales/Revenue. Fiscal year is July-June. All values USD Thousands.1 0071 0072052051 8511 8519489483943944444442013201420152016201720180500100015002000

Robert B. Kay
Executive Chairman & Chief Executive Officer
Seymour Flug
Independent Director